Key result
OSA linked to ~168% greater CV risk only in patients with intermediate polygenic risk.
Why the study?
Obstructive sleep apnea increases cardiovascular risk, but this risk is not fully captured by the apnea-hypopnea index, prompting investigation into whether a CAD polygenic risk score refines risk assessment.
Does a coronary artery disease polygenic risk score (CAD-PRS) refine cardiovascular risk assessment in individuals with obstructive sleep apnea?
Does a coronary artery disease polygenic risk score (CAD-PRS) refine cardiovascular risk assessment in individuals with obstructive sleep apnea?
Adding a coronary artery disease polygenic risk score to standard clinical risk models significantly improves cardiovascular risk stratification in patients with obstructive sleep apnea.
CAD-PRS may refine CV risk stratification in OSA; extends utility of polygenic scores in precision prevention.
Study Objectives Obstructive sleep apnea (OSA) carries increased cardiovascular (CV) risk. However, this risk is not fully captured by the apnea–hypopnea index (AHI). We investigated whether a validated coronary artery disease polygenic risk score (CAD-PRS) refines CV risk assessment in OSA. Methods We derived CAD-PRS using genome-wide genotyping data for 1,379 participants of the CoLaus|HypnoLaus cohort who underwent polysomnography. Associations between OSA, CAD-PRS, clinical factors, and incident CV events were assessed using multivariable Cox proportional hazards models. Risk stratification improvement was assessed with reclassification analyses compared to clinical risk scores (SCORE2/SCORE2-OP). Results During 7.2 years of median follow-up, 100 participants experienced CV events. A significant interaction between OSA and CAD-PRS was observed (p=0.013). The effect of OSA on CV risk differed across PRS categories. In the intermediate genetic-risk group (CAD-PRS quintiles 2–4), OSA patients (AHI ≥15/h) had a markedly higher CV risk compared to non-OSA (HR[95% CI]: 2.68[1.54–4.66]), whereas OSA did not significantly increase CV risk in either the low or high PRS strata. The complete model with OSA, CAD-PRS and their interaction allowed a significant reclassification (Net Reclassification Index 0.171, p=0.014) compared to SCORE2/SCORE2-OP and 52% of individuals at intermediate risk were reclassified as low or high CV risk. Conclusions In this population-based cohort, a CAD-PRS was associated with CV risk stratification in individuals with OSA. The impact of OSA on CV risk was greatest in individuals with intermediate genetic risk. Adding CAD-PRS and OSA to SCORE2 was associated with improved model performance and reclassification, supporting more precise CV risk assessment in OSA.
No takes yet. Share an insight, caveat, or question.
Thorball et al. (2026) studied this question. Obstructive sleep apnea increased cardiovascular risk (HR 2.68) in patients with an intermediate polygenic risk score, but did not significantly increase risk in low or high genetic risk strata.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: